PS Ratio: 3.51

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 3.51 is 42% below its estimated 5-year average of 6.10, near the low end of its estimated 5-year range (1.58–29.67).

As of 2026-10-06T15:56:00.613Z. 19.08% above its estimated 12-month average of 2.95.

CTKB PS Ratio Metrics

P/S vs. estimated history

At 3.51, P/S is below its estimated 5-year median — higher than 33% of readings in its estimated 5-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Cytek Biosciences, Inc. (CTKB)?

The P/S ratio for CTKB stock is 3.51.

Is Cytek Biosciences, Inc.'s P/S ratio high or low?

The P/S ratio of 3.51 is 42% below its estimated 5-year average of 6.10, near the low end of its estimated 5-year range (1.58–29.67).

What is the estimated TTM average P/S ratio for Cytek Biosciences, Inc. (CTKB)?

The estimated TTM average P/S ratio for CTKB stock is 2.95.

What is the estimated 3Y average P/S ratio for Cytek Biosciences, Inc. (CTKB)?

The estimated 3Y average P/S ratio for CTKB stock is 3.29.

What is the estimated 5Y average P/S ratio for Cytek Biosciences, Inc. (CTKB)?

The estimated 5Y average P/S ratio for CTKB stock is 6.10.

Showing the most recent 260 of 1,306 data points. The chart above shows the full history.

Related Metrics